Back to All Topics
Research
Research Article
2 min read
Liver and Kidney Impact Comparison
Comparative analysis of hepatic and renal effects across compound classes.
Introduction
Organ toxicity profiles differ markedly between performance-enhancing compounds.
Liver Impact Comparison
Hepatotoxicity Risk
| Compound Type | Risk Level | Mechanism | Markers |
|---|---|---|---|
| 17-alpha alkylated steroids | High | Direct toxicity | Elevated liver enzymes |
| Injectable steroids | Low | Minimal hepatic metabolism | Usually normal |
| SARMs | Variable | Hepatic metabolism | Variable elevation |
| Peptides | Very Low | Non-hepatic metabolism | Normal |
Liver Effects by Duration
| Compound | Short-term | Medium-term | Long-term |
|---|---|---|---|
| Oral steroids | Enzyme elevation | Cholestasis possible | Adenoma risk |
| Injectable steroids | Minimal | Minimal | Lipid changes |
| SARMs | Variable | Limited data | Unknown |
| Peptides | None observed | None observed | None observed |
Kidney Impact Comparison
Nephrotoxicity Profile
| Compound Type | Direct Risk | Indirect Risk | Monitoring |
|---|---|---|---|
| Steroids | Low | Blood pressure-mediated | Periodic |
| SARMs | Unknown | Limited data | Prudent |
| GH/peptides | Very low | Minimal | Basic |
| High protein intake | Low-Moderate | Combined effect | Regular |
Kidney Function Markers
| Marker | Steroids | SARMs | Peptides |
|---|---|---|---|
| Creatinine | May elevate (muscle mass) | Usually normal | Normal |
| BUN | May elevate | Usually normal | Normal |
| GFR | Usually preserved | Usually preserved | Normal |
| Proteinuria | Rare | Not documented | Not documented |
Protective Strategies
| Strategy | Liver | Kidney | Both |
|---|---|---|---|
| Hydration | Moderate | High | Yes |
| Avoid alcohol | Critical | Helpful | Yes |
| Limit NSAIDs | Helpful | Critical | Yes |
| Regular monitoring | Essential | Important | Yes |
| Cycle length limits | Critical for oral | Less critical | Yes |
Conclusion
Peptides show favorable safety profile for liver and kidney compared to oral steroids.
Stay Updated on Peptide Research
Get weekly breakdowns of new studies, dosing insights, and community protocols. No spam, unsubscribe anytime.